NCT05908929

Brief Summary

Periodontal regenerative therapy has focused on various non-surgical and surgical treatment methods. Platelet-rich fibrin (PRF) has shown to possess multiple uses, including properties that promote healing of both soft and hard tissues. In the present study, we hypothesized that the addition of PRF into periodontal pockets, as an adjunct to conventional scaling and root planing (SRP), would enhance the outcomes of non-surgical periodontal therapy. This split-mouth randomized controlled clinical trial included 26 periodontal pocket sites in 13 patients with periodontitis. The pockets were randomly assigned as either test or control sites. In the test group, PRF was placed as an adjunct to SRP, while the control group received SRP alone. Probing pocket depths (PPD), clinical attachment levels (CAL), gingival recession (GR), plaque index (PI), and gingivitis index (GI) were measured at baseline and at six weeks. The wound healing index was measured during the six-week follow-up period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 8, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 18, 2023

Completed
Last Updated

June 18, 2023

Status Verified

June 1, 2023

Enrollment Period

4 months

First QC Date

June 8, 2023

Last Update Submit

June 16, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • pocket depth

    Probing pocket depths (PPD), clinical attachment levels (CAL), gingival recession (GR), plaque index (PI), and gingivitis index (GI) were measured

    6 weeks

Study Arms (2)

patients treated with SRP and insertion of PRF

EXPERIMENTAL
Procedure: SRP and concomitant insertion of PRF membrane

patients treated with SRP

ACTIVE COMPARATOR
Procedure: SRP

Interventions

The pockets were treated with scaling and root planing (SRP) along with the simultaneous insertion of a Platelet Rich Fibrin (PRF) membrane. Blood samples were drawn without anticoagulants in 10 mL tubes, which were immediately centrifuged at 4000 rpm for 8 minutes. Upon centrifugation, the blood showed three distinct layers: the uppermost layer contained platelet poor plasma, the middle layer consisted of a fibrin clot, and the lowermost band appeared bright red due to the presence of red blood cells. The fibrin clot polymerized in a diffuse manner within the tube, which was then cut with sharp scissors and squeezed between two glass slides to obtain a thick membrane. The PRF membrane was carefully handled using a carrier and isolated with a periodontal pack dressing (Coe-Pak). All patients were followed up at one week and six weeks after the treatment.

patients treated with SRP and insertion of PRF
SRPPROCEDURE

The pockets were treated using the conventional procedure of scaling and root planing (SRP) utilizing curettes and an ultrasonic device. All patients were followed up at one week and six weeks after the treatment.

patients treated with SRP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • either gender,
  • aged 18 years or older,
  • patients without a medical history of systemic diseases,
  • patient with chronic periodontitis
  • patient with 5 or 6 mm of probing depth

You may not qualify if:

  • patients with medical history of systemic disease or bleeding disorders
  • presence of other gingival diseases (such as leukoplakia, lichen planus, pemphigoid disorders, pemphigus vulgaris, herpetic lesions, Necrotizing Ulcerative Periodontitis (NUP)
  • pregnancy
  • history of any drug usage affecting the periodontium for the past six months (such as systemic antibiotic therapy)
  • previous periodontal treatment in the last six months
  • smoking
  • teeth with untreated caries
  • endodontic lesions and grade II or more mobility
  • subjects with acute exacerbation of periodontitis
  • patients with systemic
  • disease or condition that could affect tissue healing (e.g., autoimmune disease)
  • severe furcation involvement (grade II and III)
  • abutment for prosthetic rehabilitation
  • active orthodontic therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Naples Federico II

Naples, 80123, Italy

Location

Università degli Studi di Napoli Federico II

Napoli, 80131, Italy

Location

MeSH Terms

Conditions

Periodontal PocketPeriodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor in Dental Sciences, Principal Investigator

Study Record Dates

First Submitted

June 8, 2023

First Posted

June 18, 2023

Study Start

September 15, 2022

Primary Completion

January 15, 2023

Study Completion

February 15, 2023

Last Updated

June 18, 2023

Record last verified: 2023-06

Locations